Zimmer Biomet (NYSE:ZBH) & Safe Pro Group Inc. Common Stock (NASDAQ:SPAI) Head-To-Head Contrast

Zimmer Biomet (NYSE:ZBH) and Safe Pro Group Inc. Common Stock (NASDAQ:SPAI) are both medical companies, but which is the better business? We will compare the two companies based on the strength of their dividends, analyst recommendations, profitability, earnings, risk, institutional ownership and valuation.

Analyst Ratings

This is a summary of recent ratings and target prices for Zimmer Biomet and Safe Pro Group Inc. Common Stock, as reported by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Zimmer Biomet	2	11	9	0	2.32
Safe Pro Group Inc. Common Stock	0	0	0	0	0.00

Zimmer Biomet currently has a consensus price target of $124.15, suggesting a potential upside of 27.69%. Given Zimmer Biomet’s stronger consensus rating and higher possible upside, equities research analysts clearly believe Zimmer Biomet is more favorable than Safe Pro Group Inc. Common Stock.

Valuation and Earnings

This table compares Zimmer Biomet and Safe Pro Group Inc. Common Stock”s revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Zimmer Biomet	$7.68 billion	2.52	$903.70 million	$4.45	21.85
Safe Pro Group Inc. Common Stock	$2.17 million	14.83	N/A	N/A	N/A

Zimmer Biomet has higher revenue and earnings than Safe Pro Group Inc. Common Stock.

Profitability

This table compares Zimmer Biomet and Safe Pro Group Inc. Common Stock’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Zimmer Biomet	11.77%	12.99%	7.58%
Safe Pro Group Inc. Common Stock	N/A	N/A	N/A

Institutional and Insider Ownership

88.9% of Zimmer Biomet shares are held by institutional investors. 1.0% of Zimmer Biomet shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

Summary

Zimmer Biomet beats Safe Pro Group Inc. Common Stock on 9 of the 10 factors compared between the two stocks.

About Zimmer Biomet

Zimmer Biomet Holdings, Inc., together with its subsidiaries, operates as a medical technology company worldwide. The company designs, manufactures, and markets orthopedic reconstructive products, such as knee and hip products; S.E.T. products, including sports medicine, biologics, foot and ankle, extremities, and trauma products; craniomaxillofacial and thoracic products comprising face and skull reconstruction products, as well as products that fixate and stabilize the bones of the chest to facilitate healing or reconstruction after open heart surgery, trauma, or for deformities of the chest. It also offers robotic, surgical, and bone cement products. The company's products and solutions are used to treat patients suffering from disorders of, or injuries to, bones, joints, or supporting soft tissues. It serves orthopedic surgeons, neurosurgeons, hospitals, stocking distributors, healthcare dealers, and other specialists, as well as agents, healthcare purchasing organizations, or buying groups. The company was formerly known as Zimmer Holdings, Inc. and changed its name to Zimmer Biomet Holdings, Inc. in June 2015. Zimmer Biomet Holdings, Inc. was founded in 1927 and is headquartered in Warsaw, Indiana.

About Safe Pro Group Inc. Common Stock

Safe Pro Group, Inc. engages in the provision and acquisition of security and protection products. Its products include Artificial Intelligence (AI) and Machine Learning (ML) software technology and photogrammetry analysis tools, bullet and blast resistant personal protection equipment, and aerial managed services and mission-critical uncrewed solutions. The firm operates through the following segments: Safe-PRO USA, Airborne Response, and Safe Pro AI. The company was founded by Daniyel Erdberg on December 15, 2021 and is headquartered in Aventura, FL.